Access a curated library of reports, policy submissions, data insights, and other materials informing Canada’s life sciences ecosystem.
September 15, 2021
September 15, 2021
Innovative Medicines Canada provides Health Canada with additional input regarding IMC’s March 2021 consultation submission on drugs for rare diseases.
March 26, 2021
March 26, 2021
IMC proposes a value-based, pan-Canadian rare disease strategy, built in collaboration with provinces, patients, clinicians and industry to fill gaps and meet specific needs.
Stay informed with timely, relevant content on key issues shaping our industry.
